Certificate in Addiction Management in Primary Care

Share this page

About the Certificate in Addiction Management in Primary Care

This advanced course is required for GPs progressing to Level 2 OST prescriber status. It builds on the Foundation Course and provides deeper clinical insight and practical skills.

Programme Highlights

  • Safe initiation of opioid agonist therapies
  • Switching between methadone and buprenorphine/naloxone
  • Management of special patient populations (e.g. pregnant patients, dual diagnosis)
  • Therapeutic management of:
    • Alcohol
    • Benzodiazepines
    • Z-drugs
    • Cannabis
    • Stimulants
    • Prescribed/OTC opioids
    • Enhanced referral and rehabilitation pathways

Format

  • Online blended learning videos
  • 2 Interactive workshops
  • Clinical case Workbook or Practice Improvement Project submission

Course Details

Course Director: Dr Bernard Kenny
Academic Lead: Dr Des Crowley
Course Co-ordinator: Education Department, Irish College of GPs
Further information: education@icgp.ie

Course fees

  • Members - €500
  • GP Trainees - €500
  • Non-members - €650

Cancellation Policy for Irish College of GPs Courses and Events

How do I apply?

GP and GP Trainee registration link

Registration closes at 5pm on Thursday, 25 November 2026. 

Course Duration

The course will commence on September 11, 2026 and run until March 2027. 

Participants are expected to attend two online live workshops (dates TBC), complete online learning modules and submit a Clinical Case Study, demonstrating their learning during the course. 

  1. Course launch – Friday 11th September 2026
    a.    6 video presentations; Each video is approx. 30 minutes
    b.    5 question MCQs under each video
  2. Live workshop 1 – Friday 27th November 2026, 10am – 12:30pm
  3. Live Workshop 2 – Friday 29th January 2027, 10am – 12:30pm
  4. Clinical Case Workbook or Practice Improvement Project submission – Friday 12th March 2027

Course content

Opioid Agonist Therapy
Learning Objectives:

  • Overview of pharmacology buprenorphine and methadone and rationale for use as opioid agonist therapy
  • Safe prescribing considering drug-drug interactions, patient co-morbidities
  • How to write a prescription with reference to updated PSI guidance
  • An approach to missed doses and explanation of supervision/instalment requirements and rationale

Opioid Use Disorder – Diagnoses, Assessment and Prescribing Practice
Learning Objectives:

  • Opioid use disorder diagnosis with reference to DSM-5
  • Initial assessment and screening
  • An approach to safe initiation of buprenorphine and methadone
  • Considerations when switching between opioid agonist therapies
  • Maintenance on opioid agonist therapy with reference to markers of stability e.g. urine drug screening, attendance pharmacy/clinic and presentation

Injectable Buprenorphine - Improving patient choice
Learning Objectives:

  • Clinical indications and patient selection –Buprenorphine S/C (Buvidal)
  • An approach to maintenance and dose adjustments
  • Switching from alternative opioid agonist therapy (buprenorphine SL/Methadone to Buvidal)

Benzodiazepine Misuse/Dependence in the Community
Learning Objectives:

  • Discuss the dangers of benzodiazepines in context of opioid use disorder reference to drug deaths + rx/ illicitly sourced.
  • Detox Strategies: Apply evidence-based detox protocols using diazepam equivalence, interval dispensing, and structured tapering plans.
  • Evaluate readiness for detox through motivational interviewing, drug diaries, and screening for medical or psychiatric contraindications.
  • An approach to community detox, when is residential required.

Gabapentinoids - Use, Misuse & Management
Learning Objectives:

  • Understand licensed uses and Irish prescribing trends
  • Recognise misuse patterns and clinical red flags
  • Review a common scenario in primary care
  • Apply safe prescribing and deprescribing strategies

Addiction and Adverse Childhood Events
Learning Objectives:

  • Risk factors, ACEs and Trauma
  • Resilience
  • Protective factors

Pre Requisites

Obtain the Foundation Course in Addiction Management Certificate
Obtain Hepatitis C Certificate
Obtain Overdose Management Certificate
Obtain Buprenorphine (Suboxone) Certificate

If you are a non-member, please email education@icgp.ie. We will provide you with access and enough time to complete the above modules, as they provide critical information to obtain the Level 2 Certificate

FAQs

  • All GPs who have completed the Irish College of GPs' Addiction Management in Primary Care Foundation Course are eligible to register for this course.

    This course is also the education component for becoming a recognised Level 2 OST Prescriber with the HSE.

    • Viewing of recorded content and completing MCQs
    • 2 x Live interactive virtual workshops
    • Practice Improvement Project OR Clinical case submission
  • GP and GP Trainee registration link

    Registration closes at 5pm on Thursday, 25 November 2026.